Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
359
-
Total 13F shares, excl. options
-
69.2M
-
Shares change
-
+1.09M
-
Total reported value, excl. options
-
$5.11B
-
Value change
-
+$80.7M
-
Put/Call ratio
-
0.28
-
Number of buys
-
174
-
Number of sells
-
-146
-
Price
-
$73.78
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2022
417 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q1 2022.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 359 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.2M shares
of 115M outstanding shares and own 60.05% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.41M shares), BlackRock Inc. (7.35M shares), JANUS HENDERSON GROUP PLC (6.59M shares), WELLINGTON MANAGEMENT GROUP LLP (3.24M shares), STATE STREET CORP (2.22M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (2.02M shares), Capital Research Global Investors (1.9M shares), RTW INVESTMENTS, LP (1.68M shares), Champlain Investment Partners, LLC (1.68M shares), and AXA S.A. (1.58M shares).
This table shows the top 359 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.